Search Results 601-610 of 21502 for Inhibition

1. PAC203: A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician’s Choice in Patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post Essential Thrombocythemia Myelofibrosis with Severe Thrombocytopenia (Platelet Counts <50,000/μL) (PACIFICA) - Mayo Clinic

   ... inhibitor, irrespective of dose, with a duration of 90 days orless. The 90-day period starts on the date of first administration of JAK2 inhibitor therapy ...

2. Publications - Andrej Urumov, M.D. - Mayo Clinic

   Nonpeptidic HIV protease inhibitors possessing excellent antiviral activities and therapeutic indices. PD 178390: a lead HIV protease inhibitor. Bioorg Med ...

3. Fluvoxamine (oral route) - Side effects & dosage - Mayo Clinic

   Fluvoxamine is used to treat obsessive compulsive disorder (OCD). It belongs to a group of medicines known as selective serotonin reuptake inhibitors (SSRIs).

4. Study of INCB053914 in Subjects With Advanced Malignancies - Mayo Clinic

   About this study. This is an open-label, dose-escalation study of the proviral integration site of Moloney murine leukemia virus (PIM) kinase inhibitor ...

5. Pirtobrutinib (oral route) - Side effects & dosage - Mayo Clinic

   ... inhibitor). This medicine is also used to treat chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back or did not respond ...

6. Finasteride and tadalafil (oral route) - Side effects & dosage - Mayo Clinic

   Tadalafil belongs to a group of medicines called phosphodiesterase 5 (PDE5) inhibitors. These medicines prevent an enzyme called phosphodiesterase type-5 ...

7. A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid - Mayo Clinic

   Patients who are receiving treatments known to cause or exacerbate BP (e.g., angiotensin converting enzyme inhibitors ... inhibition of ovulation initiated 2 or ...

8. A Study to Assess Safety and Effectiveness of Venetoclax in Combination With Gilteritinib in Subjects With Relapsed/Refractory Acute Myeloid Leukemia - Mayo Clinic

   Subject must not have received prior treatment with any BCL-2 inhibitor except venetoclax (both dose escalation and dose expansion). ... inhibitors (e.g. ...

9. Mitochondria vs. Alzheimer's - Mayo Clinic News Network

   As a proof of concept, the team demonstrated that partial inhibition of mitochondrial complex I with CP2 blocked cognitive decline and neurodegeneration.

10. Female sexual dysfunction - Diagnosis and treatment - Mayo Clinic

    Phosphodiesterase inhibitors. This group of medicines has had success in treating not being able to get and keep an erection, called erectile dysfunction ...